Status:
COMPLETED
Celecoxib Japan Observational Study for the Patients With Acute Pain
Lead Sponsor:
Astellas Pharma Inc
Conditions:
Patients With Traumatic Pain, Post-surgical Pain and Tooth Extract Pain
Eligibility:
All Genders
Brief Summary
This study is to assess the safety and efficacy of celecoxib on the pain relief from acute pain.
Detailed Description
Patients with traumatic pain, post-surgical and tooth extract pain will be included in this study. Patients will receive Celecoxib for 2 weeks and the efficacy on pain relief and the safety will be ev...
Eligibility Criteria
Inclusion
- Patients with traumatic pain, post-surgical pain and tooth extract pain
Exclusion
- Hyperreactive to sulfonamide
- Aspirin asthma patients
- Peptidic ulcer patients
- Serious liver disease patients
- Serious kidney disease patients
- Serious heart failure patients
- End of pregnancy
Key Trial Info
Start Date :
July 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
784 Patients enrolled
Trial Details
Trial ID
NCT01876121
Start Date
July 1 2012
End Date
April 1 2013
Last Update
September 5 2014
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Chūbu, Japan
2
Hokkaido, Japan
3
Kansai, Japan
4
Kantou, Japan